This inventor holds 4 USPTO granted patents. Top assignees: Dsm IP Assets B.v., Dsm N.v.. Active years: 2004-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2016
Title: Innovations of Petrus M M Nossin
Introduction
Petrus M M Nossin is a notable inventor based in Nederweert, Netherlands. He has made significant contributions to the field of biochemical synthesis, particularly in the production of 1,4-butanediamine. With a total of four patents to his name, Nossin's work showcases his expertise and innovative approach to biochemistry.
Latest Patents
Nossin's latest patents focus on the biochemical synthesis of 1,4-butanediamine. One patent describes a process for synthesizing this compound in a microorganism that has an increased level of ornithine decarboxylase activity compared to its native state. This increased activity is achieved through the overexpression of an ornithine decarboxylase encoding gene, which enhances translational and/or transcriptional efficiency. The process involves excreting the produced 1,4-butanediamine into a fermentation broth, from which it is subsequently recovered. Another patent also relates to a similar process, emphasizing the importance of increased N-acetylglutamate formation alongside ornithine decarboxylase activity.
Career Highlights
Throughout his career, Nossin has worked with prominent companies such as DSM IP Assets B.V. and DSM N.V. His experience in these organizations has contributed to his development as an inventor and researcher in the field of biochemistry.
Collaborations
Nossin has collaborated with notable colleagues, including Marcel G Wubbolts and Katrin Eppelmann. These partnerships have likely enriched his research and innovation efforts.
Conclusion
Petrus M M Nossin's contributions to biochemical synthesis, particularly in the production of 1,4-butanediamine, highlight his innovative spirit and expertise in the field. His patents and collaborations reflect a commitment to advancing biochemistry and its applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

